Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos
Enhanced Medication Management to Control ADRD Risk Factors Among African Americans and Latinos
批准号:
10610975
负责人:
Alvin Ramsey
金额:
$29.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-09-18 至 2024-08-31
关键词:
AddressAdherenceAdoptionAffectAfrican AmericanAfrican American populationAge YearsAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAntidiabetic DrugsAntihypertensive AgentsCaringCategoriesCommunitiesDataDiabetes MellitusDisparityEarly DiagnosisEarly InterventionElderlyElectronicsExpenditureFeedbackFutureGoalsHispanic PopulationsHypertensionLatinoLatino PopulationLogistic RegressionsMachine LearningMedicalMedication ManagementMinorityMorbidity - disease rateMovementNotificationParticipantPatientsPharmaceutical PreparationsPhaseProviderRecommendationRecording of previous eventsRiskRisk FactorsRisk ManagementRisk ReductionServicesSurveysSystemTestingTimeTrainingUnited States Agency for Healthcare Research and QualityVisitalgorithm trainingcaucasian Americancloud platformdementia riskdesignempowermentimprovedinnovationinterestmedication compliancepatient populationpillprediction algorithmpredictive modelingpredictive toolsprovider portalrandom forestsuccesstrend
中文摘要
项目总结/摘要
阿尔茨海默病和相关痴呆症(ADRD)不成比例地影响少数民族-非洲裔美国人是2x
更有可能,西班牙裔/拉丁裔比白色美国人患ADRD的可能性高1.5倍。最近,老年痴呆症
影响运动(AIM)和阿尔茨海默氏症协会支持“更好地管理风险”的建议
因素-特别是高血压和糖尿病-以降低非裔美国人的ADRD风险,
西班牙裔/拉丁裔。”药物治疗可以非常有效地控制高血压和糖尿病,但不幸的是,
对这些药物的依从性通常很低,特别是在非裔美国人和西班牙裔/拉丁裔美国人中。边际
抗高血压药物的依从性(60%-80%)不足,因为这些患者仍有显著的
发生ADRD的风险升高(与完全粘附相比高3倍,与高度粘附相比高2.5倍)。
因此,用于优化药物依从性的有效主动解决方案可以对该患者产生积极影响
人口
拟议的解决方案将是为供应商设计的药物管理服务。完整的解决方案将
包括:(A)商业上可获得的电子药丸分配器,其发送服用/错过药丸的SMS通知,(B)
基于历史数据的未来依从性评估,以及(C)提供者门户,其呈现依从性相关
信息.为了解决非裔美国人和拉丁美洲人在ADRD方面的差异,初步实施将
特别关注为这些社区的老年人提供护理的提供者。
英文摘要
Project Summary/Abstract
Alzheimer’s disease and related dementias (ADRD) disproportionately affects minorities – African Americans are 2x
more likely and Hispanics/Latinos are 1.5x more likely than white Americans to have ADRD. Recently, the Alzheimer’s
Impact Movement (AIM) and the Alzheimer’s Association supported the recommendation of “better management of risk
factors – particularly high blood pressure and diabetes – to reduce the risk of ADRD among African Americans and
Hispanics/Latinos.” Medications can be very effective in managing both hypertension and diabetes, but unfortunately
adherence to these medications is commonly low, particularly among African Americans and Hispanics/Latinos. Marginal
adherence (60%-80%) with anti-hypertensive medication is inadequate because these patients still had significantly
elevated risks (3x greater compared to fully adherent, 2.5x greater compared to highly adherent) of developing ADRD.
Hence, an effective pro-active solution for optimizing medication adherence can positively impact this patient
population.
The proposed solution will be a medication management service designed for providers. The full solution would
comprise of: (A) a commercially available electronic pill dispenser that sends SMS notifications of pills taken/missed, (B)
future adherence assessment based on historical data, and (C) a provider portal which presents adherence-related
information. To address the disparity in ADRD among African Americans and Latinos, the initial implementation will
specifically focus on providers who deliver care to older adults in these communities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金